The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis
MetadataShow full item record
AbstractMany survivors of the 2003 outbreak of severe acute respiratory syndrome (SARS) developed residual pulmonary fibrosis with increased severity seen in older patients. Autopsies of patients that died from SARS also showed fibrosis to varying extents. Pulmonary fibrosis can be occasionally seen as a consequence to several respiratory viral infections but is much more common after a SARS coronavirus (SARS-CoV) infection. Given the threat of future outbreaks of severe coronavirus disease, including Middle East respiratory syndrome (MERS), it is important to understand the mechanisms responsible for pulmonary fibrosis, so as to support the development of therapeutic countermeasures and mitigate sequelae of infection. In this article, we summarize pulmonary fibrotic changes observed after a SARS-CoV infection, discuss the extent to which other respiratory viruses induce fibrosis, describe available animal models to study the development of SARS-CoV induced fibrosis and review evidence that pulmonary fibrosis is caused by a hyperactive host response to lung injury mediated by epidermal growth factor receptor (EGFR) signaling. We summarize work from our group and others indicating that inhibiting EGFR signaling may prevent an excessive fibrotic response to SARS-CoV and other respiratory viral infections and propose directions for future research.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85018490378&doi=10.1016%2fj.antiviral.2017.03.022&partnerID=40&md5=cb73aed3e046ecc12e7743ef2bc0d331; http://hdl.handle.net/10713/12399
- Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
- Authors: Venkataraman T, Coleman CM, Frieman MB
- Issue date: 2017 Jun 15
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
- Authors: Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS
- Issue date: 2018 Oct 9
- Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus.
- Authors: Sutton TC, Subbarao K
- Issue date: 2015 May
- [Lung pathology and pathogenesis of severe acute respiratory syndrome: a report of six full autopsies].
- Authors: Pei F, Zheng J, Gao ZF, Zhong YF, Fang WG, Gong EC, Zou WZ, Wang SL, Gao DX, Xie ZG, Lu M, Shi XY, Liu CR, Yang JP, Wang YP, Han ZH, Shi XH, Dao WB, Gu J
- Issue date: 2005 Oct
- TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
- Authors: Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N
- Issue date: 2019 Mar 15